Blog Posts in July, 2015

GlaxoSmithKline, the manufacturer of Zofran, recently submitted a motion asking for consolidation of all Zofran lawsuits claiming birth defects into a multi-district litigation. The motion requested ...

Just last year one of Pfizer’s own scientists warned top executives about a possible link between birth defects and the anti-depressant drug Zoloft. At that time, changes were recommended regarding ...

Two recent studies have linked Xarelto, a blood-thinning drug manufactured by Johnson & Johnson, to an increased risk of stomach bleeds and eye hemorrhaging. In the first study, two doctors found a ...

The Consumer Financial Protection Bureau will be collecting more than $7.5 million in fines alone from Regions Financial Corporation. These fines were imposed for overdraft fees charged to consumers ...

Xarelto is a newer blood thinner that has been on the market since 2011. Its primary function is to reduce the risk of blood clots in patients who have Deep Vein Thrombosis, pulmonary embolism, or ...

A potentially fatal side effect of Invokana, as well as other SGLT2 inhibitors, is expected to lead to a flurry of lawsuits against the manufacturers of these drugs. Invokana is used in the treatment ...